NFKB1 and neoplasm: We and other researchers have shown that activation of NF-κB signaling increases ARVs expression in benign prostatic [8] and PC cells [9, 10] and blocking NF-κB signaling efficiently restores responsiveness of CRPC cells to anti-androgen treatment by decreasing ARVs expression [9].